Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Bone Marrow Stem Cells for Diabetic Foot
NCT02796079Phase 1Unknown
- Start
- Jan 2015
- Primary completion
- Dec 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised trial of mesenchymal stem cells in diabetic foot disease (DFD) and peripheral vascular disease (PVD) (2 arms). Primary endpoint: Area of diabetic foot ulcers at 3 months. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
diabetic foot disease (DFD)peripheral vascular disease (PVD)
Beyond the preview
Go deeper on NCT02796079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02796079.